Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-06

Clinical Trial Update: Serum and Intraocular Levels of Erythropoietin and VEGF in Type 2 Diabetes Patients With Proliferative Retinopathy

View source ↗

Summary

This completed clinical trial studied serum and intraocular levels of erythropoietin and vascular endothelial growth factor (VEGF) in adults with Type 2 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Università degli Studi di Brescia | Conditions: Diabetic Retinopathy | Status: COMPLETED